MU vs PFE: Which Is the Better Buy?
Side-by-side comparison of Micron Technology, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Micron Technology, Inc. · Technology
$421.51
-20.2% upside to fair value
Low Conviction
Grade D
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MU |
PFE |
| Current Price |
$421.51 |
$26.91 |
| Fair Value Estimate |
$336.45 |
$35.00 |
| Upside to Fair Value |
-20.2%
|
+30.1%
|
| Market Cap |
$475.4B |
$153.0B |
| Forward P/E |
19.7x
|
9.5x
|
| EV / EBITDA |
12.8x
|
13.8x
|
| Price / Sales |
8.2x
|
2.4x
|
| Price / FCF |
21.6x
|
16.8x
|
| Revenue Growth YoY |
+74.9%
|
-1.6%
|
| Gross Margin |
58.4%
|
70.3%
|
| Operating Margin |
48.5%
|
24.7%
|
| Return on Equity |
40.8%
|
9.0%
|
| Dividend Yield |
0% |
6.4% |
| FCF Yield |
4.64%
|
5.9%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Micron Technology, Inc. is a leading semiconductor company specializing in memory and storage solutions, including DRAM and NAND products, which are critical for AI, data centers, mobile, and embedded applications. The company benefits from strong revenue growth of 74.9% year-over-year and exceptional profitability with a net margin of 41.5% and return on equity of 40.8%. Despite these strengths …
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
MU |
PFE |
| Zone Low |
$252.34 |
$25.00 |
| Zone High |
$285.98 |
$29.00 |
| In Buy Zone? |
No
|
Yes
|